[1]
A. C. Millar, D. S. Elterman, L. Goldenberg, B. Van Asseldonk, A. Curtis, and K. Jarvi, “A survey of Canadian urologists’ opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer”, CUAJ, vol. 10, no. 5-6, pp. 181–4, Jun. 2016.